Growth-hormone secretagogues

Details for Australian Patent Application No. 2005277389 (hide)

Owner Elixir Pharmaceuticals, Inc.

Inventors Geesaman, Bard J.

Agent Cullens

Pub. Number AU-A-2005277389

PCT Pub. Number WO2006/023608

Priority 60/621,343 22.10.04 US; 60/602,713 18.08.04 US

Filing date 18 August 2005

Wipo publication date 2 March 2006

International Classifications

A61K 38/08 (2006.01) Medicinal preparations containing peptides - Peptides having 5 to 11 amino acids

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/023608 Priority application(s): WO2006/023608

17 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005277392-Process for the synthesis C-2, C-3 substituted N-alkylated indoles useful as CPLA2 inhibitors

2005277385-Method and apparatus for network congestion control using queue control and one-way delay measurements